LDLR and metabolic dysfunction-associated steatotic liver disease: On a high-fat/high-cholesterol diet, LDLR−/− mice become obese, develop insulin resistance and accumulate hepatic triglycerides, with inflammation and hepatic fibrosis associated with NAFLD progression to NASH25,26.